OGN (STOCKS)
Organon & Co.
$13.440000
+0.000000 (+0.00%)
Prev close: $13.440000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph T. Morrissey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,534.72M
- Employees
- 10,000
- P/E (TTM)
- 14.32
- P/B (TTM)
- 3.91
- Dividend Yield
- 59.52%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
7
Hold
5
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.71 | $0.84 | -0.1276 | -15.23% |
|
Dec 2025 (Q4)
|
$0.63 | $0.73 | -0.1044 | -14.22% |
|
Sep 2025 (Q3)
|
$1.01 | $0.95 | +0.0643 | +6.80% |
|
Jun 2025 (Q2)
|
$1.00 | $0.96 | +0.0427 | +4.46% |
Financial Statements
| Revenues | $6.16B |
| Benefits Costs and Expenses | $5.63B |
| Cost Of Revenue | $2.91B |
| Costs And Expenses | $5.63B |
| Gross Profit | $3.26B |
| Operating Expenses | $2.72B |
| Selling, General, and Administrative Expenses | $1.73B |
| Other Operating Expenses | $993.00M |
| Operating Income/Loss | $537.00M |
| Income/Loss From Continuing Operations After Tax | $246.00M |
| Income/Loss From Continuing Operations Before Tax | $537.00M |
| Income Tax Expense/Benefit | $291.00M |
| Income Tax Expense/Benefit, Deferred | $83.00M |
| Interest Expense, Operating | $491.00M |
| Net Income/Loss | $246.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $246.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $246.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.94 |
| Diluted Earnings Per Share | $0.94 |
| Basic Average Shares | 780,513,000 |
| Diluted Average Shares | 783,858,000 |
| Assets | $13.00B |
| Current Assets | $4.93B |
| Inventory | $1.37B |
| Other Current Assets | $3.56B |
| Noncurrent Assets | $8.06B |
| Fixed Assets | $1.28B |
| Other Non-current Assets | $6.79B |
| Liabilities | $12.09B |
| Current Liabilities | $2.50B |
| Accounts Payable | $983.00M |
| Other Current Liabilities | $1.52B |
| Noncurrent Liabilities | $9.59B |
| Long-term Debt | $8.57B |
| Other Non-current Liabilities | $1.02B |
| Equity | $903.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $903.00M |
| Liabilities And Equity | $13.00B |
| Net Cash Flow From Operating Activities | $850.00M |
| Net Cash Flow From Operating Activities, Continuing | $850.00M |
| Net Cash Flow From Investing Activities | $168.00M |
| Net Cash Flow From Investing Activities, Continuing | $168.00M |
| Net Cash Flow From Financing Activities | -$524.00M |
| Net Cash Flow From Financing Activities, Continuing | -$524.00M |
| Exchange Gains/Losses | $75.00M |
| Net Cash Flow | $569.00M |
| Net Cash Flow, Continuing | $494.00M |
| Comprehensive Income/Loss | $324.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $324.00M |
| Other Comprehensive Income/Loss | $78.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $78.00M |